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Introduction
Life support of an organism is ensured by functional unity of all its systems, including regulatory ones -nervous, immune, endocrine, etc. [1] [2] [3] [4] The traditional notion that immune responses are autonomous, episodic, unidirectional, simple and linear, the artificial notion of the lymphoid system as something isolated does not correspond to reality and limits the development of diagnostic and treatment technologies. 5 
General evidence of complexity of natural mechanisms of homeostatic regulation in the organism Functional unity between the immune, nervous and endocrine systems
The first two systems have common functioning principlesinduction of specific responses, memory, a branched anatomical structure, capacity for modification of other body system functions, presence of common receptors in nerve and lymphoid cells, formation of common biochemical regulators and messengers by these cells. To these should be added the immunotropic activity of sex and other hormones, endocrine-like action of immune mediators, a direct release of peptide hormones by immunocompetent cells, formation of cytokines, and presence of a common biochemical mediator in the functioning of cyclic nucleotides сAMP/cGMP. Any change in the cell function of these systems occurs via signals from the external environment, which are realized through molecular receptors for signal molecules of ligands of the same hormones, cytokines, neuromediators, pathogens, etc. 6, 7 Another example of the immune response complexity is the cooperation of immunocompetent cells. 8, 9 A classic example of this process is a trinomial cooperation in the phenomenon of immune response induction. [10] [11] [12] There is also a constant direct or distant interaction between the investing tissue cells and lymphoid cells, the latter and the vessel wall endothelium, T-lymphocytes (T) and antigen-recognizing cells, T-cells and B-lymphocytes (B), T-lymphocytes and leukocytes, lymphocytes and leukocytes with intercellular matrix, etc.
Known mechanisms of cell interactions are: (1) Intercellular junctions of membranes -cell adhesion through complementarity of receptors that are long-term (in solid tissues) and short-term (reversible intercellular synapses);
(2) Interaction through synthesis and secretion of soluble substances that affect the adhesion in two variants -distant action, for example, through endocrine hormones, and local action -through mediators such as cytokines. Cell adhesion molecules, which bind to the corresponding receptors of target-cells, are selectins, mucin-like vascular addressins, integrins, and immunoglobulin super-family. The result of these interactions is implementation of the core process of immune system functioning -lymphopoiesis.
Complexity of pre-immune and specific defence mechanisms
It is realized not simultaneously, but stretched in time. 13, 14 In this context, the natural resistance (including species immunity), not part of immune responses, defending the body against chemical, physical, biological pathogenic agents, is a connecting link with specific immune mechanisms, as it prepares antigen for their deployment and its signalling on B-cells. Otherwise, it is difficult to develop active immunity against thymus-dependent antigens.
Non-specific mechanisms develop immediately after penetration of a causative agent and operate constantly throughout the infection process -they are particularly active during the first 4 hours. This period is marked by the development of reactions that carry elements of specificity, such as professional phagocytosis, antibody-dependent killing, γ-interferon. Specific mechanisms begin to develop in the period from 7-8 days to 2-4 weeks since the appearance of pathogen in the body and realize ITH (immediate-type hypersensitivity), DTH (delayed-type hypersensitivity), immune memory, antibody formation (primary, repeated immune responses), immunodeficiency, phenomena of tolerance, paralysis, deviation, enhancement, formation of sensitized lymphocytes, lymphokines, transplantation immunity, transplant-against-host reaction, immune surveillance. 15 The notion of complexity also includes the phenomenon of non-specific immune response regulation by thymus and bone-marrow substances (myelopeptides), fragments of immunoglobulins, cytokines, complement system, lipid peroxidation products, carbohydrate and water-salt metabolism, proteins and peptides, enzymes, etc. 10, 14, 16 
Correlations between immune-and-laboratory and clinical parameters
Patients with bronchopulmonary diseases demonstrated a definite dependence of clinical and functional characteristics on the type of immunodeficiency. For example in case of IgA deficiency, there was a decrease in TLC (total lung capacity) and VLC (vital lung capacity). The average value of oxygen tension was lower in children with hypoxemia than in patients with IgA deficiency. At the same time, clinical manifestations and functional breathing problems in children with chronic bronchopulmonary diseases on the background of isolated Ahypoimmunoglobulinemia unfolded more favourably, and in case of complex immunopathology, they were more severe and extensive. 8, 10, 12 Using Kj-coefficient, three leading immune parameters were sampled from patients with secretory otitis media and chronic obstructive bronchitis in the acute period: 7, 17 T-and B-lymphocytes, Th (T-helpers) and CTL (cytotoxic T-lymphocytes), IgM, which proved to be correlated with clinical parameters -negative inoculation of microflora, low, 1st-degree conduction of acoustic meatus, myxoedema or fever, coughing, pulmonary rales.
On the clinical model of cortico-dependent bronchial asthma, the key clinical parameters -asthma attacks, cough, shortness of breath, pulmonary rales -were associated with CD3+, CD8+, CD4+, CD19+ lymphocytes. After modulation of patients with sodium nucleinate, the main disease symptoms proved to be dependent on the severity of skin tests for staphylococcal or streptococcal allergens, as well as on the amount of T-cytotoxic lymphocytes.
In patients suffering from urogenital viral infection (UGVI) with chlamydia, ureaplasmosis and trichomoniasis, the significant correlations between lymphocyte phenotype, local and systemic cytokine parameters were determined using the Spearman's coefficient. The combination of UGVI and chlamydia caused 13 associative links of clinical parameters (duration of subjective sensations, period of rash regression, remission, quality of life, clinical index) with a correlation coefficient (>0.8) and with subpopulations of lymphocytes, 14 -with parameters of systemic status and 10 -with local cytokine status, which had a definite pathogenetic and prognostic value. 18 In children who survived severe asphyxia, 19 we found a direct correlation between the phagocytic number in the umbilical cord blood and the long rupture-to-delivery interval and the inverse correlation between gestosis and the level of CD95+ lymphocytes, NBTac (active reduction of nitro blue tetrazolium). Positive associative link was observed between gestosis in the maternal organism and CD8+ lymphocytes. Diverse correlations were observed between IgG concentration on the 5th day and breathing disorder, duration of artificial lung ventilation, gestosis, acute renal failure in newborns, and duration of jaundice. We also determined the influence of immune status on the resistance degree in children who survived severe asphyxia. There is a statistically significant negative correlation between the level of CD3+ lymphocytes and the resistance degree, the index of acute diseases; and the smaller the number of CD4+, CD8+, CD19+ cells, the higher the index of acute diseases. IgA level in the umbilical cord blood correlated with atopic dermatitis and anaemia. The detected correlations between immune parameters and the resistance degree in children under 1 year confirm that the frequency of acute respiratory-viral diseases directly depends on the immunologic responsiveness of children who survived severe asphyxia. As a result of predicting the frequency of acute infectious diseases in the first year of a child's life, a predictive model was constructed, which included 26 immune parameters. The model's predictive power is determined by the determinism coefficient (R2), which describes 77% of the weight contribution of these parameters to the variability of the acute disease index. 19 
Correlations of immune and laboratory parameters under normal and pathological conditions
A definite interpretation of existing strong correlations between parameters of laboratory or any other status has not been formulated. It has been suggested that the more correlations between parameters, the worse the functioning of immune system. 14, 20 We hold an opposite point of view, since it was established that the number of correlations of immune and laboratory parameters in clinical remission stage increased after treatment of a wide range of diseases. In principle, this phenomenon is an indirect criterion for evaluation of efficacy of therapeutic interventions. It has been demonstrated that the components of the immune and laboratory status form a certain matrix of integrative connections in healthy individuals -one-time healthy blood donors. Thus, populations and subpopulations of lymphocytes have a direct correlation with the level of total lymphocytes; cells with markers CD3+, CD4+, CD19+ proved to be positively correlated and the phagocytic numbernegatively correlated with the rod nuclear cells. CD3+, CD4+ lymphocytes were positively dependent on segmented leukocytes.
T-cells were negatively dependent on basophils, CD4+ lymphocytes -on eosinophils, and the phagocytic number was positively dependent on the same cells. Thus, proceeding from the presented data, the nosological variants of meningitis (serous or purulent) leave their impact on typical changes of the laboratory status components, including integrative processes.
Influence of disease combinations on immunopathology
The achievement of recent years is the establishment of a wide range of variability of immune reactivity in various diseases, which in turn is the material basis for development of new pathological processes, which requires correction. The situation is regarded as simple when the patient has one disease, but in case of several diseases it becomes controversial, as any particular main diagnosis largely determines the disease treatment. This section presents data on the immunological examination of patients who suffer from a combination of diseases of different and similar genesis, complicated with true and pseudoallergy. 9, 11, 17 The subject matters for analysis were the typical formulas of immune system disorders (FISD), including signal laboratory markers, which specify vector and degree of variations from the norm level (Table 1 ).
The data in Table 1 show that all 13 investigated variants of disease combinations, according to FISD, modify a set of diagnostically significant parameters, which indicate a change in the mechanism of immunopathology. At the same time, in case of combination of diseases of various geneses, we observe mainly the formation of a new-quality response in patients. For example, in case of combination of bronchopulmonary and autoimmune pathologies (idBA+CAIT) into the final formula -ТАТ 
Influence of disease combinations on the immunocorrection effects
Combinations and allergisation of diseases turned out to be factors for modification of modulator effects. The drugs of different origin and mechanism of action (synthetic -Galavite, native -Sodium nucleinate) were analysed for hematologic, immune, bacteriological, clinical parameters of patients who suffer from mixed-type bronchial asthma (MBA), purulent soft tissue infection (PSTI) in combination with allergic dermatitis (AD), true eczema (TE), COPD, AD. 6, 7, 13, 15 Signalling targets of the immunocorrection action were similarly determined in patients with mono-and combined pathology in comparative aspect ( Table 2 ). The presented data indicate that, on the one hand, there is complete absence of the so-called passport modulator targets, and on the other hand, there is practically the same dependence of these targets on the clinical features of diseases.
It was established that the severity of normalization of immune and hematologic tests under the influence of

Efficacy of combined immunocorrection
Practice shows that in a number of cases it is necessary to conduct a combined immunotherapy to increase the efficacy of treatment of severe diseases, which, however, re-quires obligatory preliminary approbation of influences. 6, 9, 17, [21] [22] [23] [24] [25] [26] In this case, the selection of drugs for combinations cannot be random, but should be wellfounded. Clinical models of PID (proinflammatory disease) and NILD (non-specific inflammatory lung diseases) of various genesis -deep pyoderma (DP), exacerbation of chronic pyelonephritis (ECPN), exacerbation of chronic salpingooophoritis (ECSO); MBA, MBA+COPD, were used to estimate the clinical and laboratory efficacy of Roncoleukin, Isoprinosine, Licopid, CigaPan, Hypoxen, Superlymph, Derinat, Sodium nucleinate (SN), Thymogen, Gabriglobine, Polyoxidonium, Bronchomunal. After immunotherapy, we conducted an integral evaluation of the changes in hematologic, biochemical, bacteriological, clinical, immune parameters in patients, and using Kj, 15 determined the main components of ICTF of conventional disease treatment with mono-and combined therapy.
Integral evaluation showed that in patients with deep significant -Sodium nucleinate in case of MBA. The established rating of treatment activity showed that in case of MBA, the highest activity was achieved due to the use of TT + Hypoxen + Bronchomunal → further + Hypoxen + Sodium nucleinate → further + Hypoxen; in case of COPD -+ Hypoxen + Sodium nucleinate + Bronchomunal → + Hypoxen; in case of MBA+COPD the maximum efficacy was reached with combination of TT + Hypoxen + Bronchomunal; further → + Hypoxen + Bronchomunal or + Sodium nucleinate. The presented data show the obvious advantage of combined immunotherapy ( Table 3 ). Table 3 indicate that when comparing with regard to TT the ICTF components of 6 variants of combined therapy and 18 variants of monoimmunotherapy of patients suffering from PID and NILD, a certain new quality is formed.
The data in
Thus, the complexity of response, regulation, therapeutic correction of immune system function is postulated, which implies cooperation between regulatory systems, immunocompetent and auxiliary cells, systemic and regional immunity, presence of body-wide and specific defence mechanisms, clinical and laboratory parameters; internal and external regulators, active influence on these processes by combination, allergisation of diseases, as well as the distinct advantage of combined immunotherapy of patients. Conventional signs: idBA -infectious-dependent bronchial asthma, CAIT -chronic autoimmune thyroiditis, COB -chronic obstructive bronchitis, CC -chronic cholecystitis, CLL -chronic lymphocytic leukemia, MM -multiple myeloma, CP -chronic pneumonia, MBA -mixed-type bronchial asthma, COPD -chronic obstructive pulmonary disease, GU -gastric ulcer. DUduodenal ulcer, AD -allergic dermatitis, PA -pseudo-allergy, FIC -frequently ill children, FIC + ENT -the same + diseases of Ear, Nose, and Throat. At the top of formulas: + (increase), -(decrease), at the bottom of formulas -degree of variation (1insignificant, 2 -significant and 3 -very significant); TAT-thyroglobulin autoantibodies, CIC -circulating immune complexes, L -leukocytes, MWM -medium-weight molecules, Lph -Lymphocytes Conventional signs: * rank1 -significant change (stimulation or suppression) >66% of the parameters; rank 2 ->33-66% of the parameters; rank 3 -<33% of the parameters; ** level of efficacy: I -insignificant, II -moderate, III -significant. ICTFs -"self" immune correction targets formula, independent of the basic treatment of diseases. The lower the sum of ranks, the higher the effectiveness of treatment; IL -interleukins, Lph -Lymphocytes with expression of LFA-1 integrin receptors
